跳至主要内容
临床试验/NCT01301261
NCT01301261Unknown不适用

The Effect of Sugammadex on Hemodynamics, Oxygenation, End-tidal CO2, Entropy and Bispectral Index Intraoperatively Without Steroid Neuromuscular Blocker

University of Athens1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2010年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
1
主要终点
Entropy

研究概览

简要总结

Sugammadex is used to reverse the neuromuscular blocking effect of steroid neuromuscular blockers. Its cardiovascular effects and effect on brain cortex, if any, may be associated to the reversal of the neuromuscular block. The aim of the study was to investigate the pure effects of sugammadex in the absence of the agonist.

详细描述

Three groups of patients undergoing elective major surgery and given cis-atracurium for muscle relaxation are studied.

Group 1 receives 2 mg/kg of sugammadex when a count of two of the train of four appears Group 2 receives 4 mg/kg of sugammadex when a posttetanic count 1-3 appears Group 3 receives 16 mg/kg of sugammadex three minutes after administration of cis-atracurium.

Heart rate, arterial blood pressure, oxygen saturation, end-tidal CO2, entropy and bispectral index are recorded every three minutes

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients ASA I-III scheduled for elective major surgery
  • both sexes

排除标准

  • patients hypertensive
  • treated with antihypertensive drugs

研究组 & 干预措施

sugammadex 2 mg/kg

Active Comparator

2 mg/kg of sugammadex are given when a response of two counts of train of four are present

干预措施: sugammadex (Drug)

4 mg/kg of sugammadex

Active Comparator

4 mg/kg of sugammadex are given when a posttetanic count 1-3 appears

干预措施: Sugammadex 4 mg/kg (Drug)

Sugammadex 16 mg/kg

Active Comparator

Sugammadex 16 mg/kg are given three minutes after the injection of cis-atracurium

干预措施: Sugammadex 16mg/kg (Drug)

结局指标

主要结局

Entropy

时间窗: every three minutes

次要结局

  • hemodynamics(every three minutes)

研究者

发起方
University of Athens
申办方类型
Other
责任方
Principal Investigator
主要研究者

Argyro Fassoulaki

MD, PhD, DEAA

University of Athens

研究点 (1)

Loading locations...

相似试验